Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × tositumomab I-131 × Clear all

NCT00577629 2017-05-30

Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

Phase 2 Completed

39 enrolled 11 charts

Lymphoma, B-Cell